SRXH
SRx Health Solutions Inc.·Healthcare
0.13
7.581%(−0.01)
Market ClosedLast Updated: — ET
52W L: $0.0852W H: $2.02
SRx Health Solutions Inc.·Healthcare
NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced hedging its decentralized finance (DeFi) portfolio with investment in Gold. The Company has also reduced its hedge on emerging markets.
The Company will update shareholders in the near future on the proposed timing to close the EMJX transaction The Company will update shareholders in the near future on the proposed timing to close the EMJX transaction
NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced increasing its ownership in the common stock of Opendoor Technologies Inc., a leading digital platform for residential real estate transactions. The Company has also further reduced its short position across its cryptocurrency portfolio of Bitcoin and Ethereum and is now net long its holdings.
NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that on February 18, 2026, it received a public warning letter (the “Letter”) from the NYSE Regulation Staff of the New York Stock Exchange (the “Exchange”) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the “Company Guide”).
Executed Definitive Agreement to Acquire EMJ Crypto Technologies ("EMJX"), a “Gen 2” Digital-Asset Treasury Platform, Anticipated to Close in first half of Calendar 2026
NORTH PALM BEACH, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has redeemed 17,500 shares of its Series A Preferred Stock pursuant to the terms of the Series A Preferred Stock, representing approximately 125,000,000 shares of common stock on an as-converted basis. On October 31, 2025 the Company issued and sold in a private placement 19,035 shares of the Series A Preferred Stock for aggregate proceeds of approximately $15.23 million.
